|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Delayed-Enhancement Cardiovascular Magnetic Resonance Coronary Artery Wall Imaging显示文摘 | Susan B. Yeon Adeel Sabir Melvin Clouse Pedro O. Martinezclark Dana C. Peters Thomas H. Hauser C. Michael Gibson Reza Nezafat David Maintz Warren J. Manning René M. Botnar | 2007 | Journal of the American College of Cardiology2007，，5： | 1 |
| 2 | Cardiac bio- markers-the old and the new: a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 3 | Cardiac bio-markers-the old and the new a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coronary Ar-tery Disease2010，21，4： | 1 |
| 4 | Cardiac biomarkers -the old and the new: A review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 5 | Cardiac bio- markers - the old and the new:a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 6 | Cardiac bio markers the old and the new: a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 7 | Cardiac biomarkers-the old and the new:a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 8 | Association of smoking with improved myocardial perfusion and the angiographic char-acterization of myocardial tissue perfusion after fibrinolytic therapy for ST - segment elevation myocardial infarction 显示文摘 | Kirtane AJ Martinezclark P Rahman AM | 2005 | J Am Coil Cardiol2005，45，2： | 1 |
| 9 | Cardiac biomarkers-the old and the new a review显示文摘 | Singh V Martinezclark P Pascual M | 2010 | Coron Artery Dis2010，21，4： | 1 |
| 10 | 在接受择期门诊手术治疗的机械瓣膜患者进行抗凝治疗过程中对ACC/AHA指南的依从性显示文摘This study sought to establish the practice patterns of a diverse group of academic physicians, in the management of periprocedural anticoagulation for patients with mechanical heart valves, to study adherence to American College of Cardiology/ American Heart Association(ACC/AHA) guidelines. Physicians(n=140) were surveyed to assess strategies for the periprocedural anticoagulation of patients with bileaflet mechanical heart valves undergoing 2 common outpatient procedures. Six patient scenarios with graded risk profiles were presented for each valve location(mitral and aortic). In >90% of high-risk patient scenarios, for which the ACC/AHA guidelines recommend periprocedural anticoagulation, anticoagulation was recommended, with minimal differences between physician specialties. However, periprocedural anticoagulation was also recommended in >70% of non-high-risk scenarios, for which the ACC/AHA guidelines recommend no periprocedural anticoagulation. Noncardiologists recommended anticoagulation more often in non-high-risk patients(p< 0.01), especially for patients with aortic valve prostheses. Thus, academic physicians appropriately recommend periprocedural anticoagulation for high-risk patients with mechanical heart valves who undergo elective procedures. However, these data specifically suggest variability in practice for non-high-risk patients that are discordant with current ACC/AHA guidelines, with differences by treating specialty especially notable in this risk subset. | Kirtane A. J. Rahman A. M. Martinezclark P. 刘文秀(译) 杜媛(校) | 2006 | 世界核心医学期刊文摘(心脏病学分册)2006，2，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员